LOADING
Comparing Eli Lilly and Company (LLY) and Visa Inc (V) across the Health Care and Financials sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | LLY | V |
|---|---|---|
| Price | $1,148.84 | $366.13 |
| Change Today | -0.53% | -0.04% |
| Market Cap | $1.03T | $683.6B |
| P/E Ratio | 41.0 | 31.2 |
| Forward P/E | 35.7 | 24.4 |
| PEG Ratio | 1.69 | 1.66 |
| EPS | $28.03 | $11.75 |
| Revenue Growth (YoY) | 55.5% | 14.4% |
| Profit Margin | 35.0% | 50.8% |
| Return on Equity | 107.5% | 61.2% |
| Dividend Yield | 0.54% | 0.73% |
| Beta | 0.51 | 0.75 |
| 52-Week High | $1,249.45 | $373.97 |
| 52-Week Low | $619.40 | $293.28 |
| Volume | 2.9M | 7.8M |
Eli Lilly and Company is the larger company by market capitalization. Visa Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Visa Inc offers a higher dividend yield for income investors. Visa Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.